Literature DB >> 26884905

Role of diffusion-weighted magnetic resonance imaging in differentiating malignancies from benign ovarian tumors.

Xinhua Fan1, Hongbin Zhang1, Shuang Meng1, Jing Zhang1, Chuge Zhang1.   

Abstract

OBJECTIVE: We conducted a case-control study to evaluate the diagnostic values of computed tomography (CT) and diffusion-weighted magnetic resonance imaging (DW-MRI) in differentiating malignancies from benign ovarian tumors and a meta-analysis to further confirm our results on DW-MRI.
METHODS: Totally 64 patients pathologically confirmed as ovarian cancer were included in this study. CT scan and DWI-MRI were performed and analyzed to get compared with pathological results, thereby assessing their accuracy, sensitivity and specificity. Meta-analysis was conducted by database searching and strict eligibility criteria, using STATA 12.0 (Stata Corp, College Station, TX, USA) software.
RESULTS: The accuracy, sensitivity, specificity, positive predictive value and negative predictive value for diagnosis of ovarian cancer in CT were 81.82%, 84.48%, 76.67%, 87.50% and 71.88%, respectively; those in DW-MRI were 89.77%, 93.10%, 83.33%, 91.53% and 86.21%, respectively. The Kappa coefficient of DW-MRI (K = 0.771) compared with pathological results was higher than CT (K = 0.602). The average apparent diffusion coefficient values of DW-MRI in diagnosis of benign and malignant ovarian tumors suggested statistically significant difference (1.325 ± 0.269×10(-3) mm(2)/s vs. 0.878 ± 0.246×10(-3) mm(2)/s, P < 0.001). Meta-analysis results showed that the combined sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio of DW-MRI in discriminating benign versus malignant ovarian tumors were 0.93, 0.88, 7.70, 0.08 and 101.24, respectively. The area under the summary receiver operating characteristic curve was 0.95.
CONCLUSIONS: Both CT and DW-MRI were of great diagnostic value in differentiating malignancies from benign ovarian tumors, while DW-MRI was superior to CT with higher accuracy, sensitivity and specificity.

Entities:  

Keywords:  Ovarian cancer; apparent diffusion coefficient value; case-control; computed tomography; diffusion-weighted magnetic resonance imaging; meta-analysis

Year:  2015        PMID: 26884905      PMCID: PMC4723750     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  37 in total

Review 1.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

2.  Computed tomography adnexal mass score to estimate risk for ovarian cancer.

Authors:  Joseph T Santoso; Aimee Robinson; Sri Suganda; Sirinya Praservit; Jim Y Wan; Fred Ueland
Journal:  Arch Gynecol Obstet       Date:  2013-08-31       Impact factor: 2.344

Review 3.  Functional MR imaging of the female pelvis.

Authors:  Takashi Koyama; Kaori Togashi
Journal:  J Magn Reson Imaging       Date:  2007-06       Impact factor: 4.813

4.  World Medical Association publishes the Revised Declaration of Helsinki.

Authors:  P Nischal M
Journal:  Natl Med J India       Date:  2014 Jan-Feb       Impact factor: 0.537

5.  Solid non-invasive ovarian masses on MR: histopathology and a diagnostic approach.

Authors:  Yumiko O Tanaka; Satoshi Okada; Toyomi Satoh; Koji Matsumoto; Tsukasa Saida; Akinori Oki; Hiroyuki Yoshikawa; Manabu Minami
Journal:  Eur J Radiol       Date:  2010-06-23       Impact factor: 3.528

6.  Incidental adnexal masses detected at low-dose unenhanced CT in asymptomatic women age 50 and older: implications for clinical management and ovarian cancer screening.

Authors:  Perry J Pickhardt; Meghan E Hanson
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

Review 7.  Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques.

Authors:  Pegah Mohaghegh; Andrea G Rockall
Journal:  Radiographics       Date:  2012-10       Impact factor: 5.333

Review 8.  Value of magnetic resonance imaging for the diagnosis of ovarian tumors: a review.

Authors:  Marc Bazot; Emile Daraï; Jinane Nassar-Slaba; Clarisse Lafont; Isabelle Thomassin-Naggara
Journal:  J Comput Assist Tomogr       Date:  2008 Sep-Oct       Impact factor: 1.826

9.  Magnetic resonance imaging as a diagnostic tool in case of ovarian masses in girls and young women.

Authors:  Monika Bekiesińska-Figatowska; Elzbieta Jurkiewicz; Beata Iwanowska; Maria Uliasz; Anna Romaniuk-Doroszewska; Hanna Bragoszewska; Alicja Ceran; Andrzej Olszewski
Journal:  Med Sci Monit       Date:  2007-05

10.  Value of diffusion-weighted magnetic resonance imaging in the characterization of complex adnexal masses.

Authors:  Salvatore Cappabianca; Francesco Iaselli; Alfonso Reginelli; Alfredo D'Andrea; Fabrizio Urraro; Roberto Grassi; Antonio Rotondo
Journal:  Tumori       Date:  2013 Mar-Apr
View more
  5 in total

Review 1.  In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer.

Authors:  Rossella Canese; Delia Mezzanzanica; Marina Bagnoli; Stefano Indraccolo; Silvana Canevari; Franca Podo; Egidio Iorio
Journal:  Front Oncol       Date:  2016-06-28       Impact factor: 6.244

2.  Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI.

Authors:  Auni Lindgren; Maarit Anttila; Suvi Rautiainen; Otso Arponen; Annukka Kivelä; Petri Mäkinen; Kirsi Härmä; Kirsi Hämäläinen; Veli-Matti Kosma; Seppo Ylä-Herttuala; Ritva Vanninen; Hanna Sallinen
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

Review 3.  Diagnostic accuracy of DWI in patients with ovarian cancer: A meta-analysis.

Authors:  Xia Yuan; Linghong Guo; Wei Du; Fei Mo; Ming Liu
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

4.  The Diagnostic Performance of Maximum Uptake Value and Apparent Diffusion Coefficient in Differentiating Benign and Malignant Ovarian or Adnexal Masses: A Meta-Analysis.

Authors:  Xianwen Hu; Zhigang Liang; Chuanqin Zhang; Guanlian Wang; Jiong Cai; Pan Wang
Journal:  Front Oncol       Date:  2022-02-09       Impact factor: 6.244

Review 5.  Quantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats.

Authors:  Sandy Napel; Wei Mu; Bruna V Jardim-Perassi; Hugo J W L Aerts; Robert J Gillies
Journal:  Cancer       Date:  2018-11-01       Impact factor: 6.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.